Key result
Atrial fibrillation linked to ~3-fold higher cardiovascular death risk versus matched controls.
Why the study?
Understanding the pattern of causes of death and relative risks in patients with AF compared to the non-AF population is essential for planning optimal care.
Does prevalent atrial fibrillation increase the risk of specific causes of death compared to a non-atrial fibrillation population?
Cohort (n=6,877,929)
Does prevalent atrial fibrillation increase the risk of specific causes of death compared to a non-atrial fibrillation population?
Prevalent atrial fibrillation is associated with a nearly 3-fold increased risk of cardiovascular and cerebrovascular death compared to individuals without AF, with risk strongly stratified by CHA2DS2-VASc score.
Answers are grounded in this paper and cite their sources.
Supports CV risk mitigation in prevalent AF; leaves open whether intensified strategies improve survival in prospective trials.
Background: Atrial fibrillation (AF) is associated with increased risks of adverse events including stroke and all-cause death.Understanding the pattern of causes of death (COD) with the relative risks in patients with AF compared to the non-AF population is essential in planning optimal care for patients with AF.We aimed to analyze the COD and its relative risks in patients with AF, using a nationwide population-based cohort.Methods: Using the Korean nationwide claims database, people aged 40 or older who received health examinations in 2009 were included if they had no missing values (n = 6,877,929).In total the study included 40,585 people with AF and 6,837,344 without AF.COD was defined by International Classification of Diseases, Tenth Revision, Clinical Modification (ICD-10-CM) diagnostic codes.Comparison between the AF and non-AF groups was performed with Multivariate Cox proportional regression model.Results: In the AF group, cardiovascular diseases were the most common COD, causing 39.8% of all deaths, compared with 19.0% for non-AF subjects.The AF group was associated with a higher risk of death from cardiovascular and cerebrovascular diseases by almost 3-fold than the matched non-AF group (hazard ratios [HR], 3.082; 95% confidence intervals [CIs], 2.963-3.205for cardiovascular diseases; HR, 2.981; 95% CI, 2.799-3.175for cerebrovascular diseases, all P < 0.001).Among patients with AF, the risks of all-cause, cardiovascular, and cerebrovascular death were well-stratified by CHA 2 DS 2 -VASc scores.The risk of cerebrovascular death was 11 times higher among patients with a CHA 2 DS 2 -VASc score 7. Conclusion: Compared to non-AF individuals, patients with AF had a higher risk of death from cardiovascular and cerebrovascular diseases, and the mortality risks were wellstratified by the CHA 2 DS 2 -VASc score.Integrated care management of cardiovascular and cerebrovascular diseases for patients with AF might help mitigate mortality.
No takes yet. Share an insight, caveat, or question.
Kim et al. (2024) conducted a cohort in Atrial Fibrillation (n=6,877,929). Atrial Fibrillation vs. Non-Atrial Fibrillation was evaluated on Cardiovascular death (HR 3.082, 95% CI 2.963-3.205, p=<0.001). Atrial fibrillation was associated with a nearly 3-fold higher risk of cardiovascular death compared to a matched non-atrial fibrillation population.
Synapse has enriched 10 related papers. Consider them for comparative context: